drugset / Trial / NCT00493064

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

NCT00493064

Phase 2/3 Completed 63 enrolled Palo Alto Medical Foundation
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Niacin, a B vitamin, may act as a vasodilator to encourage earlier formation of collateral blood vessels that may serve to bypass the obstructed vein in the eye. The topical steroid eye drops are aimed at reducing swelling in the retina, until the collateral vessels have a chance to develop.

Timeline

Start
2006-10
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule 500 mg Topical
Subject Prednisolone Other / unclassified Topical